Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Updated on: December 22,2023

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Updated on:December 22,2023

Nuclear radiologists 'outsmart' prostate cancer with an apparently ineffective drug

bySaarland UniversityProfessor Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Credit: Saarland University/Thorsten MohrWhen a non-scientist tries to imagine a scientis

Updated on: December 22,2023

Nuclear radiologists 'outsmart' prostate cancer with an apparently ineffective drug

bySaarland UniversityProfessor Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Credit: Saarland University/Thorsten MohrWhen a non-scientist tries to imagine a scientis

Updated on:December 22,2023

Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

January 2024Leah LawrenceNew data indicate that the use of tubes that automatically collect less blood in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions without affecting

Updated on: February 18,2024

Small-Volume Blood Collection Tubes Can Reduce Transfusions in Intensive Care

January 2024Leah LawrenceNew data indicate that the use of tubes that automatically collect less blood in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions without affecting

Updated on:February 18,2024

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on: December 18,2023

Patients with cancer, suppressed immune system at high risk for severe COVID if treated with systemic drug therapies

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPatients with cancer and a weakened immune system who are treated with immunotherapies tend to fare far worse from COVID-19 than t

Updated on:December 18,2023

Obstacles for breast cancer prevention in high-risk Black women

by Misti Crane,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainBlack women at high risk of breast cancer face a variety of obstacles that may keep them from care that could prevent ca

Updated on: December 22,2023

Obstacles for breast cancer prevention in high-risk Black women

by Misti Crane,The Ohio State UniversityCredit: Unsplash/CC0 Public DomainBlack women at high risk of breast cancer face a variety of obstacles that may keep them from care that could prevent ca

Updated on:December 22,2023

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on: January 10,2024

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on:January 10,2024

Skin cancer: New therapy option to prevent metastases

byMedical University of ViennaA, Invadopodia index of MMPi treated wells normalized to DMSO control in 3 independent screening plates as indicated; B, MTS signal values of B16-F10 and WM983C cel

Updated on: January 04,2024

Skin cancer: New therapy option to prevent metastases

byMedical University of ViennaA, Invadopodia index of MMPi treated wells normalized to DMSO control in 3 independent screening plates as indicated; B, MTS signal values of B16-F10 and WM983C cel

Updated on:January 04,2024

Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a

by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len

Updated on: December 26,2023

Revealing one of the mechanisms by which thyroid cancer becomes resistant to lenvatinib-a

by Shinshu UniversityThe EGFR-mediated pathway, which is not targeted by lenvatinib, is activated for survival in thyroid cancer cells under the potent inhibition of the VEGFR and FGFR families by len

Updated on:December 26,2023

Body fat percentage vs. BMI: Which is important?

by Taylor Barnes,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainThe start of a new year for many means the start of a new health and fitness journey. Claire Edgemon, senior registere

Updated on: May 06,2024

Body fat percentage vs. BMI: Which is important?

by Taylor Barnes,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainThe start of a new year for many means the start of a new health and fitness journey. Claire Edgemon, senior registere

Updated on:May 06,2024

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on: July 17,2024

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on:July 17,2024

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Updated on: December 18,2023

Barriers to early clinical trial access for adolescents and young adults still exist

byEuropean Society for Medical OncologyYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congre

Updated on:December 18,2023